Classification of Prostate Cancer in 3D Magnetic Resonance Imaging Data based on Convolutional Neural Networks

被引:0
作者
Rippa, Malte [1 ]
Schulze, Ruben [1 ]
Himstedt, Marian [2 ]
Burn, Felice [3 ]
机构
[1] FUSE-AI GmbH, Grosser Burstah 44-46, Hamburg
[2] University of Lubeck, Ratzeburger Allee 160, Lubeck
[3] Cantonal Hospital Aarau, Tellstrasse 25, Aarau
关键词
Computer Vision; Deep Learning; MRI; Prostate Cancer;
D O I
10.1515/cdbme-2024-0116
中图分类号
学科分类号
摘要
Prostate cancer is a commonly diagnosed cancerous disease among men world-wide. Even with modern technology such as multi-parametric magnetic resonance tomography and guided biopsies, the process for diagnosing prostate cancer remains time consuming and requires highly trained professionals. In this paper, different convolutional neural networks (CNN) are evaluated on their abilities to reliably classify whether an MRI sequence contains malignant lesions. Implementations of a ResNet, a ConvNet and a ConvNeXt for 3D image data are trained and evaluated. The models are trained using different data augmentation techniques, learning rates, and optimizers. The data is taken from a private dataset, provided by Cantonal Hospital Aarau. The best result was achieved with a ResNet3D, yielding an average precision score of 0.4583 and AUC ROC score of 0.6214. © 2024 by Walter de Gruyter Berlin/Boston.
引用
收藏
页码:61 / 64
页数:3
相关论文
共 12 条
[1]  
Aldoj N., Lukas S., Dewey M., Penzkofer T., Semiautomatic classification of prostate cancer on multiparametric mr imaging using a multi-channel 3d convolutional neural network, European Radiology, (2019)
[2]  
Arif M., Schoots I., Castillo T., Bangma C., Krestin G., Roobol M., Niessen W., Veenland J., Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multiparametric mri, European radiology, (2020)
[3]  
Armato S., Petrick N., Chen Q., Xu X., Hu S., Li X., Zou Q., Li Y., Computer-aided diagnosis - a transfer learning approach for classification of clinical significant prostate cancers from mpmri scans, Medical Imaging 2017, (2017)
[4]  
Jose M., Castillo T., Arif M., Niessen W.J., Schoots I.G., Veenland J.F., Automated classification of significant prostate cancer on mri: A systematic review on the performance of machine learning applications, Cancers, 12, 6, (2020)
[5]  
Gordetsky J., Epstein J., Grading of prostatic adenocarcinoma current state and prognostic implications, Diagn Pathol, 11, 25, (2016)
[6]  
Karimi D., Nir G., Fazli L., Black P., Goldenberg L., Salcudean S., Deep learning-based gleason grading of prostate cancer from histopathology images - role of multiscale decision aggregation and data augmentation, IEEE journal of biomedical and health informatics, 24, 5, pp. 1413-1426, (2020)
[7]  
Li H., Lee C., Chia D., Lin Z., Huang W., Tan C., Machine learning in prostate mri for prostate cancer: Current status and future opportunities, Diagnostics (Basel, Switzerland), 2, (2022)
[8]  
Liu Z., Mao H., Wu C., Feichtenhofer C., Darrell T., Xie S., A convnet for the 2020s, (2022)
[9]  
Oestmann P., Wang C., Savic L., Hamm C., Stark S., Schobert I., Gebauer B., Schlachter T., Lin M., Weinreb J., Batra R., Mulligan D., Zhang X., Duncan J., Chapiro J., Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (hcc) versus non-hcc on contrast-enhanced mri of the liver, European radiology, 31, 7, pp. 4981-4990, (2019)
[10]  
Rawla P., Epidemiology of prostate cancer, World journal of oncology, 10, (2019)